BioCentury
ARTICLE | Clinical News

AST-OPC1: Additional Phase I/IIa data

September 26, 2016 7:00 AM UTC

Data from 5 patients with a complete cervical SCI who received a single injection of 10 million cells of AST-OPC1 in the open-label, dose-escalation, U.S. Phase I/IIa SCiStar trial showed that all 5 p...